Literature DB >> 2403127

Invasive carcinoma of the vulva. Changing trends in surgical management.

D Cavanagh1, J V Fiorica, M S Hoffman, W S Roberts, S C Bryson, J P LaPolla, D P Barton.   

Abstract

Four hundred fifteen patients who had invasive carcinoma of the vulva were treated with primary surgery from July 1, 1955, through June 30, 1989. Three hundred seventy-six (90%) of the patients had squamous carcinoma. Two hundred fourteen patients (52%) had radical vulvectomy with inguinofemoral lymphadenectomy. Twenty-four patients (6%) underwent radical vulvectomy with pelvic exenteration for advanced disease, and 55 patients (13%) had nonradical operations. The remaining 122 patients (29%) underwent radical vulvectomy, inguinofemoral lymphadenectomy, and pelvic lymphadenectomy. The primary morbidity was associated with lymphedema (8.6%) and groin wound breakdown (54%). No intraoperative deaths occurred among the 415 patients treated surgically, but there were 17 deaths (4%) within 28 days of operation. The absolute 5-year survival rate was 85% in patients with negative inguinofemoral lymph nodes and 39% when these lymph nodes were positive for metastatic carcinoma. The overall absolute 5-year survival rate was 67%.

Entities:  

Mesh:

Year:  1990        PMID: 2403127     DOI: 10.1016/0002-9378(90)91114-r

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Analysis of non-squamous vulvar cancer cases: A 21-year experience in a single center.

Authors:  Derya Akdağ Cırık; Rukiye Kalyoncu; Işın Üreyen; Tolga Taşçı; Nurettin Boran; Ahmet Özfuttu; Taner Turan; Gökhan Tulunay
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

2.  Safety and feasibility of single-incision radical vulvectomy: a novel approach for the treatment of vulvar cancer.

Authors:  Liqing He; Gaowen Chen; Xiaoxuan Li; Youhong Zheng; Mengting Wu; Huiyan Wang; Xiaohong Liu; Wuqi He; Xiaodan Liu; Shaozhuo Huang; Fan Lin; Weixin Liao; Ying Ma; Yifeng Wang
Journal:  Ann Transl Med       Date:  2021-02

Review 3.  Recurrent vulvar cancer.

Authors:  Emery M Salom; Manuel Penalver
Journal:  Curr Treat Options Oncol       Date:  2002-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.